- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about CMND
Recent news which mentions CMND
Why iMedia Brands Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
April 12, 2023
From Benzinga
From InvestorPlace
Why Kalera Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 11, 2023
From Benzinga
Why Is Virgin Orbit (VORB) Stock Down 27% Today?
April 11, 2023
From InvestorPlace
Why Is PLx Pharma (PLXP) Stock Down 38% Today?
April 11, 2023
From InvestorPlace
Why Is Clearmind Medicine (CMND) Stock Up 56% Today?
April 11, 2023
From InvestorPlace
Why National CineMedia Shares Are Trading Higher By Around 111%; Here Are 20 Stocks Moving Premarket
April 11, 2023
From Benzinga
From InvestorPlace
From Benzinga
From Benzinga
Why Bullfrog AI Holdings Shares Are Trading Higher By 73%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 04, 2023
From Benzinga
Gold Rises Sharply; AMC Entertainment Shares Plunge
April 04, 2023
From Benzinga
From InvestorPlace
Psyched: 22 States With Reform Bills, Ketamine Therapy Services Today, Oscars On Shrooms & More
March 20, 2023
From Benzinga
Why Bank Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
March 13, 2023
From Benzinga
US Stocks Mostly Higher; Dow Rises 75 Points
March 13, 2023
From Benzinga
From InvestorPlace
From Benzinga
Psyched: Hawaii And Minnesota's Bills, Studying 2C-B Vs. Psilocybin, Filament CEO, Plus Brock Pierce And Jeremy Gardner Discuss The Industry's Future And More
February 27, 2023
From Benzinga
SciSparc And Clearmind Reveal Three Unique Combinations Of Future Psychedelic-Based Compounds
February 22, 2023
From Benzinga
Novel Combination Of Cannabis-Like Compound With Classical Psychedelics Searches IP Coverage In US
February 15, 2023
From Benzinga
EXCLUSIVE: Next-Generation Psychedelics, MEAI - The Road Ahead
February 01, 2023
Tickers
CMND
From Benzinga
Israeli Biotech Develops Ketamine Analogue To Treat Major Depression With Promising Results
January 31, 2023
Tickers
CMND
From Benzinga
Psyched: States With Psychedelics Legalization Bills, Next-Gen Molecule For Addiction Treatment And More
January 25, 2023
From Benzinga
From InvestorPlace
EXCLUSIVE: Next-Generation Psychedelics, MEAI - What And When
January 24, 2023
Tickers
CMND
From Benzinga
EXCLUSIVE: Next-Generation Psychedelics, MEAI - How And Why, An Israeli Scientist Explains
January 23, 2023
Tickers
CMND
From Benzinga
Next-Generation Psychedelics: The Case Of MEAI And Its Potential To Treat Addiction
January 20, 2023
Tickers
CMND
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.